The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Minimizing Exposure of Offspring: Primary Therapeutic Objective | Effect of Maternal Psychiatric Disorders | Risks of Antepartum and Postpartum Exposure to Psychotropic Medication | FDA Reproductive Safety Ratings | Dosage Management: Perinatal Pharmacokinetics | Antidepressants | Mood Stabilizers | Antipsychotics | Anxiolytics | Future Directions and General Recommendations | References

Excerpt

The management of mental illness during pregnancy and lactation is a complicated clinical challenge encompassing two concomitant medical conditions (i.e., pregnancy and a psychiatric disorder) that requires consideration of the welfare of at least two patients (i.e., mother and child). Various nonpharmacological treatment options for maternal mental illnesses during the antepartum and postpartum periods are beyond the scope of this chapter. Viable treatment options must be available, accessible, affordable, and effective for the illness, and in many cases, this may involve pharmacotherapy. Unfortunately, definitive treatment guidelines for perinatal psychotropic medications remain unavailable. In the two decades since the initial iteration of this chapter, there has been an enormous expansion in the reproductive safety literature focusing on psychotropic medications.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).